Recent Finacing
Recent Raise
Inthera Bioscience is a Swiss biopharmaceutical company developing orally delivered small-molecule inhibitors of intracellular protein–protein interactions to block aberrant signaling in solid tumors, with HPV-associated programs in preclinical development.
